rgistic Antitumor Effects of Immune Cell-Viral Biotherapy
Date: 6.4.2006
Targeted biological therapies hold tremendous potential for treatment of cancer, yet their use has been limited by constraints on delivery and effective tumor targeting.
We combined an immune effector cell population [cytokine-induced killer (CIK) cells] with an oncolytic viral therapy to achieve directed delivery to, and regression of, tumors in both immunodeficient and immunocompetent mouse models. Preinfection of CIK cells with modified vaccinia virus resulted in a prolonged eclipse phase with the virus remaining hidden until interaction with the tumor. Whole-body imaging revealed that the cells retained their ability to traffic to and to infiltrate the tumor effectively before releasing the virus.
These results illustrate the potential of combining biotherapeutics for synergistic effects that more effectively treat cancer.
"Source":[ http://www.sciencemag.org/cgi/content/abstract/311/5768/1780].
Related articles
Researchers Identify Ovarian Cancer Biomarkers - Researchers have identified markers unique to the cells of blood vessels running through ovarian tumors (12.3.2007)
